http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10692477

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 168
issn 1476-5810
1476-5829
issueIdentifier 2
pageRange 160-168
publicationName Veterinary and Comparative Oncology
startingPage 160
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_993bd938049b5ca2d859c0fbc7a6ab8b
bibliographicCitation Waite A, Balkman C, Bailey D, Kiselow M, Flory A, Beaulieu BB, Lewis LD, McEntee M. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer. Vet Comparative Oncology. 2012 Aug 21;12(2):160–8. doi: 10.1111/j.1476-5829.2012.00350.x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ffedf341014508fb277ac0412ddd266
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d707a9d865df316d6d9e0131de98bd68
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e34dadee3a5d578475d2733c44239e99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dd0e4e49bd0ed2d84dc290bcda31ce2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a88a20a6d5111dc5f126906a3933ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96f3d311c2b9e2659ba8035cc3d82457
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01b94e3f46c67a2d417da89bc9f84589
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2ac5b5385e7b3c405da6cb4017060c2
date 2012-08-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/j.1476-5829.2012.00350.x
https://pubmed.ncbi.nlm.nih.gov/22905693
isPartOf https://portal.issn.org/resource/ISSN/1476-5829
https://portal.issn.org/resource/ISSN/1476-5810
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35529
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer
discusses http://id.nlm.nih.gov/mesh/M0025279
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0184558
http://id.nlm.nih.gov/mesh/M0443608
http://id.nlm.nih.gov/mesh/M0006057
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003879Q000627
http://id.nlm.nih.gov/mesh/D004283Q000188
http://id.nlm.nih.gov/mesh/D043823Q000627
http://id.nlm.nih.gov/mesh/D016572Q000627
http://id.nlm.nih.gov/mesh/D012878Q000662
http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D004285
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D043823Q000008
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D016572Q000008
http://id.nlm.nih.gov/mesh/D003879Q000008
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D012878Q000188
http://id.nlm.nih.gov/mesh/D000077143
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71463825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123134263
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7811
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25246316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16404350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49867938
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124

Showing number of triples: 1 to 71 of 71.